Literature DB >> 29924956

Subclinical Hyperthyroidism.

Bernadette Biondi1, David S Cooper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29924956     DOI： 10.1056/NEJMcp1709318

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Subclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care.

Authors:  Deborah McCahon; M Sayeed Haque; James Parle; Fd Richard Hobbs; Lesley M Roberts
Journal:  Br J Gen Pract       Date:  2020-02-27       Impact factor: 5.386

3.  Metabolic Changes after Radioiodine Correction of Grade 1 and Grade 2 Subclinical Hyperthyroidism.

Authors:  Lucia Russo; Thi Ngoc Huyen Nguyen; Aglaia Kyrilli; Martin Robin; Pierre Bel Lassen; Rodrigo Moreno-Reyes; Bernard Corvilain
Journal:  Eur Thyroid J       Date:  2021-01-25

4.  Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.

Authors:  M L Monzani; F Piccinini; G Boselli; R Corleto; G Margiotta; R P Peeters; M Simoni; G Brigante
Journal:  J Endocrinol Invest       Date:  2022-08-21       Impact factor: 5.467

5.  Levothyroxine treatment and gastric juice pH in humans: the proof of concept.

Authors:  Camilla Virili; Giovanni Bruno; Maria Giulia Santaguida; Lucilla Gargano; Ilaria Stramazzo; Corrado De Vito; Alessia Cicenia; Giulia Scalese; Barbara Porowska; Carola Severi; Marco Centanni
Journal:  Endocrine       Date:  2022-04-27       Impact factor: 3.925

Review 6.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

7.  Genetic Thyrotropin Regulation of Atrial Fibrillation Risk Is Mediated Through an Effect on Height.

Authors:  Mingjian Shi; Ali M Manouchehri; Christian M Shaffer; Nataraja Sarma Vaitinadin; Jacklyn N Hellwege; Joe-Elie Salem; Lea K Davis; Jill H Simmons; Dan M Roden; M Benjamin Shoemaker; Jane F Ferguson; Jonathan D Mosley
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

8.  Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy.

Authors:  Pauline Faucher; Frédéric Beuvon; Daniela Fignani; Guido Sebastiani; Georgia Afonso; Zhicheng Zhou; Bertrand Dousset; Christian Boitard; Francesco Dotta; Roberto Mallone; Etienne Larger
Journal:  Diabetologia       Date:  2021-09-14       Impact factor: 10.122

9.  Hyperthyroidism Prevalence in China After Universal Salt Iodization.

Authors:  Chuyuan Wang; Yongze Li; Di Teng; Xiaoguang Shi; Jianming Ba; Bing Chen; Jianling Du; Lanjie He; Xiaoyang Lai; Yanbo Li; Haiyi Chi; Eryuan Liao; Chao Liu; Libin Liu; Guijun Qin; Yingfen Qin; Huibiao Quan; Bingyin Shi; Hui Sun; Xulei Tang; Nanwei Tong; Guixia Wang; Jin-An Zhang; Youmin Wang; Yuanming Xue; Li Yan; Jing Yang; Lihui Yang; Yongli Yao; Zhen Ye; Qiao Zhang; Lihui Zhang; Jun Zhu; Mei Zhu; Zhongyan Shan; Weiping Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

Review 10.  Thyrotropin, Hyperthyroidism, and Bone Mass.

Authors:  Se-Min Kim; Vitaly Ryu; Sari Miyashita; Funda Korkmaz; Daria Lizneva; Sakshi Gera; Rauf Latif; Terry F Davies; Jameel Iqbal; Tony Yuen; Mone Zaidi
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.